Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasmapheresis vs Plasma Infusion in MCI APOE4 Homozygotes
NCT03887741Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Sep 2021
- Primary completion
- Feb 2024
- Countries
- 1
01
Overview
Phase 1, open-label trial in Mild Cognitive Impairment (MCI) (3 arms), sponsored by Mayo Clinic. Primary endpoint: Adverse Events at 1 year. Started Sep 2021; status: completed.
02
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT03887741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03887741.